SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-023560
Filing Date
2022-06-22
Accepted
2022-06-22 16:19:30
Documents
2
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1571
2 EX-24 DOCUMENT attachment1.htm EX-24 4405
  Complete submission text file 0000899243-22-023560.txt   7499
Mailing Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141
Business Address 222 JACOBS STREET SUITE 200 CAMBRIDGE MA 02141 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Issuer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CEREVEL THERAPEUTICS HOLDINGS, INC. 222 JACOBS STREET, SUITE 200 CAMBRIDGE MA 02141
Business Address
Varma Suneet (Reporting) CIK: 0001934467 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39311 | Film No.: 221032292